Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 211

1.

Oncologic Outcomes of Partial Nephrectomy for Stage T3a Renal Cell Cancer.

Shvero A, Nativ O, Abu-Ghanem Y, Zilberman D, Zaher B, Levitt M, Fridman E, Portnoy O, Ramon J, Dotan ZA.

Clin Genitourin Cancer. 2017 Nov 7. pii: S1558-7673(17)30332-4. doi: 10.1016/j.clgc.2017.10.016. [Epub ahead of print]

PMID:
29174471
2.

Allium Stents: A Novel Solution for the Management of Upper and Lower Urinary Tract Strictures.

Bahouth Z, Moskovitz B, Halachmi S, Nativ O.

Rambam Maimonides Med J. 2017 Oct 16;8(4). doi: 10.5041/RMMJ.10313. Review.

3.

Histopathologic Differences between Jewish and Arab Population in Israel at First-Time Presentation with Bladder Cancer.

Avitan O, Bahouth Z, Halachmi S, Shprits S, Masarwa I, Sabo E, Moskovitz B, Nativ O.

Biomed Res Int. 2017;2017:8239601. doi: 10.1155/2017/8239601. Epub 2017 Jul 24.

4.

A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.

Davis N, Shtabsky A, Lew S, Rona R, Leibovitch I, Nativ O, Cohen M, Mor Y, Lindner U, Glickman Y, Matzkin H, Tsivian A, Gofrit O, Yossepovitch O.

Eur Urol Focus. 2016 Oct 31. pii: S2405-4569(16)30149-3. doi: 10.1016/j.euf.2016.10.004. [Epub ahead of print]

PMID:
28753799
5.

[KIDNEY DISEASES IN NORTH ISRAEL ACCORDING TO KIDNEY BIOPSIES - BNAI-ZION MEDICAL CENTER 14 YEARS' EXPERIENCE].

Storch S, Willner N, Toubi A, Croitoru S, Wolfson V, Matar I, Grushka E, Odeh M, Wolfovits E, Schiff E, Rosner Y, Toubi E, Kessel A, Ben Izhak O, Moskovitz B, Nativ O.

Harefuah. 2016 Sep;155(9):537-541. Hebrew.

PMID:
28530079
6.

Unraveling Antimicrobial Susceptibility of Bacterial Networks on Micropillar Architectures Using Intrinsic Phase-Shift Spectroscopy.

Leonard H, Halachmi S, Ben-Dov N, Nativ O, Segal E.

ACS Nano. 2017 Jun 27;11(6):6167-6177. doi: 10.1021/acsnano.7b02217. Epub 2017 May 16.

PMID:
28485961
7.

Bovine serum albumin-glutaraldehyde (BioGlue®) tissue adhesive versus standard renorrhaphy following renal mass enucleation: a retrospective comparison.

Bahouth Z, Moskovitz B, Halachmi S, Nativ O.

Ther Adv Urol. 2017 Feb 1;9(3-4):67-72. doi: 10.1177/1756287217697662. eCollection 2017 Mar-Apr.

8.

Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545.

Abassi Z, Hamoud S, Hassan A, Khamaysi I, Nativ O, Heyman SN, Muhammad RS, Ilan N, Singh P, Hammond E, Zaza G, Lupo A, Onisto M, Bellin G, Masola V, Vlodavsky I, Gambaro G.

Oncotarget. 2017 May 23;8(21):34191-34204. doi: 10.18632/oncotarget.16573.

9.

The use of bovine serum albumin-glutaraldehyde tissue adhesive (BioGlue®) for tumor bed closure following open partial nephrectomy.

Bahouth Z, Halachmi S, Shprits S, Burbara Y, Avitan O, Masarwa I, Moskovitz B, Nativ O.

Actas Urol Esp. 2017 Oct;41(8):511-515. doi: 10.1016/j.acuro.2016.12.003. Epub 2017 Mar 7. English, Spanish.

PMID:
28283215
10.

Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules.

Nakhleh MK, Amal H, Jeries R, Broza YY, Aboud M, Gharra A, Ivgi H, Khatib S, Badarneh S, Har-Shai L, Glass-Marmor L, Lejbkowicz I, Miller A, Badarny S, Winer R, Finberg J, Cohen-Kaminsky S, Perros F, Montani D, Girerd B, Garcia G, Simonneau G, Nakhoul F, Baram S, Salim R, Hakim M, Gruber M, Ronen O, Marshak T, Doweck I, Nativ O, Bahouth Z, Shi DY, Zhang W, Hua QL, Pan YY, Tao L, Liu H, Karban A, Koifman E, Rainis T, Skapars R, Sivins A, Ancans G, Liepniece-Karele I, Kikuste I, Lasina I, Tolmanis I, Johnson D, Millstone SZ, Fulton J, Wells JW, Wilf LH, Humbert M, Leja M, Peled N, Haick H.

ACS Nano. 2017 Jan 24;11(1):112-125. doi: 10.1021/acsnano.6b04930. Epub 2016 Dec 21.

11.

Update in urethral stents.

Bahouth Z, Meyer G, Yildiz G, Nativ O, Moskovitz B.

Arch Esp Urol. 2016 Oct;69(8):601-606.

PMID:
27725336
12.

Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury.

Masola V, Zaza G, Gambaro G, Onisto M, Bellin G, Vischini G, Khamaysi I, Hassan A, Hamoud S, Nativ O, Heyman SN, Lupo A, Vlodavsky I, Abassi Z.

PLoS One. 2016 Jul 28;11(7):e0160074. doi: 10.1371/journal.pone.0160074. eCollection 2016. Erratum in: PLoS One. 2017 Apr 10;12 (4):e0175618.

13.

Successful Endovascular Control of Renal Artery in a Transplant Kidney During Nephron Sparing Surgery (NSS) for Large Centrally Located Tumor.

Shprits S, Moskovits B, Sachner R, Nativ O.

Urol Case Rep. 2016 Apr 2;6:53-5. doi: 10.1016/j.eucr.2016.02.012. eCollection 2016 May.

14.

[INTERMEDIATE-TERM FOLLOW-UP OF PATIENTS UNDERGOING ACTIVE SURVEILLANCE FOR SMALL RENAL MASS: INDICATIONS FOR SURGICAL INTERVENTION].

Bahouth Z, Halachmi S, Moskovitz B, Nativ O.

Harefuah. 2016 Jan;155(1):37-40, 67. Hebrew.

PMID:
27012073
15.

Heparanase 2 expression inversely correlates with bladder carcinoma grade and stage.

Gross-Cohen M, Feld S, Naroditsky I, Nativ O, Ilan N, Vlodavsky I.

Oncotarget. 2016 Apr 19;7(16):22556-65. doi: 10.18632/oncotarget.8003.

16.

[MULTICENTER EXPERIENCE WITH ALLIUM URETERAL STENT FOR THE TREATMENT OF URETERAL STRICTURE AND FISTULA].

Bahouth Z, Meyer G, Halachmi S, Nativ O, Moskowitz B.

Harefuah. 2015 Dec;154(12):753-6, 806. Hebrew.

PMID:
26897774
17.

Nephron Sparing Surgery for Renal Mass: Is There Any Difference between Oncocytoma and Malignant Lesions.

Bahouth Z, Halachmi S, Masarwa I, Avitan O, Nativ O.

Urol Int. 2017;98(2):134-137. doi: 10.1159/000444332. Epub 2016 Feb 19.

PMID:
26890924
18.

Results of a Randomised Controlled Trial Comparing Intravesical Chemohyperthermia with Mitomycin C Versus Bacillus Calmette-Guérin for Adjuvant Treatment of Patients with Intermediate- and High-risk Non-Muscle-invasive Bladder Cancer.

Arends TJ, Nativ O, Maffezzini M, de Cobelli O, Canepa G, Verweij F, Moskovitz B, van der Heijden AG, Witjes JA.

Eur Urol. 2016 Jun;69(6):1046-52. doi: 10.1016/j.eururo.2016.01.006. Epub 2016 Jan 20.

PMID:
26803476
19.

Endothelial Function Assessment in Patients with Erectile Dysfunction.

Bahouth Z, Zreik R, Graif A, Nativ O, Halachmi S, Pillar G.

Isr Med Assoc J. 2015 Nov;17(11):682-6.

20.

The role of hyperthermia as a treatment for non-muscle invasive bladder cancer.

Bahouth Z, Halachmi S, Moskovitz B, Nativ O.

Expert Rev Anticancer Ther. 2016;16(2):189-98. doi: 10.1586/14737140.2016.1126515. Epub 2015 Dec 19. Review.

PMID:
26618756

Supplemental Content

Support Center